Zyversa Therapeutics Inc
(ZVSA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,278 | 5,902 | 0 | 0 | 0 |
| Other current assets | 235 | 235 | 0 | 0 | 0 |
| TOTAL | $2,835 | $6,363 | $0 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 15 | 17 | N/A | N/A | N/A |
| Intangibles | 111,981 | 111,981 | 0 | 0 | 0 |
| Other Non-Current Assets | 123 | 145 | 0 | 0 | 0 |
| TOTAL | $112,119 | $112,144 | $N/A | $N/A | $N/A |
| Total Assets | $114,954 | $118,506 | $0 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,381 | 6,026 | 0 | 0 | 0 |
| Accrued Expenses | 2,113 | 2,054 | 0 | 0 | 0 |
| TOTAL | $8,578 | $8,188 | $0 | $0 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 331 | 0 | 0 | 0 |
| TOTAL | $9,277 | $10,655 | $N/A | $N/A | $N/A |
| Total Liabilities | $17,855 | $18,843 | $0 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 58 | N/A | N/A | N/A | N/A |
| Common Shares | 1 | 0 | 0 | 0 | 0 |
| Retained earnings | -8,465 | -4,921 | 0 | 0 | 0 |
| TOTAL | $97,098 | $99,663 | $0 | $0 | $0 |
| Total Liabilities And Equity | $114,954 | $118,506 | $0 | $0 | $0 |